论文部分内容阅读
目的观察盐酸氨溴索治疗新生儿肺炎的疗效。方法选取我院2013年1月~2016年6月收治的新生儿肺炎患儿110例,分成实验组与对照组,各55例,给予对照组常规治疗方案,实验组则在常规治疗方案的基础上应用盐酸氨溴索进行辅助治疗,对比两组患儿治疗结束后的实际效果、肺部啰音症状改善程度、住院治疗时间及不良反应的发生情况。结果经不同方案治疗后,对照组的总有效率为74.55%(41/55),实验组为94.55%(52/55),差异有统计学意义(P﹤0.05);两组患者治疗后的肺部啰音症状缓解有效率情况及住院治疗时间分别为74.55%(41/55)、(7.5±0.5)天与94.55%(52/55)、(5.5±0.5)天,且在治疗期间仅对照组中有4例患儿出现不良反应,差异有统计学意义(P﹤0.05)。结论应用盐酸氨溴索配合常规治疗方案辅助新生儿肺炎治疗的临床效果确切满意,肺部啰音症状明显改善,住院时间缩短,且不良反应不易发生,有效性及安全性更高,故此疗法值得在临床上良好的使用推广。
Objective To observe the efficacy of ambroxol hydrochloride in the treatment of neonatal pneumonia. Methods 110 cases of neonatal pneumonia admitted from January 2013 to June 2016 in our hospital were divided into experimental group and control group, 55 cases in each group. The control group received routine treatment and the experimental group was on the basis of routine treatment On the application of ambroxol hydrochloride adjuvant therapy, compared the actual effect of two groups of children after treatment, the improvement of pulmonary rales symptoms, hospitalization time and adverse reactions. Results After the treatment with different regimens, the total effective rate of the control group was 74.55% (41/55), the experimental group was 94.55% (52/55), the difference was statistically significant (P <0.05); after treatment The effective rate of pulmonary rales symptom relief and hospitalization were 74.55% (41/55), (7.5 ± 0.5) days and 94.55% (52/55), respectively (5.5 ± 0.5) days, and only There were 4 cases of adverse reactions in the control group, the difference was statistically significant (P <0.05). Conclusion Ambroxol hydrochloride combined with conventional treatment of neonatal pneumonia treatment is indeed satisfactory clinical results, pulmonary rales significantly improved symptoms, shorter hospital stay, and adverse reactions are not likely to occur, the effectiveness and safety of higher, so the therapy is worth In the clinical use of good promotion.